Status: Not yet recruiting
Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.
The goal of this clinical trial is to evaluate the safety and tolerability of TMX in adults patients with cystic fibrosis who do not have mutations currently eligible for therapy with modulator drugs. The main questions it aims to answer is: . What medical problems do participants have when taking drug TMX? Participants will: * Take drug TMX every day for 6 months * Visit the clinic once every 28 days for checkups and tests
Participants needed: 35
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Azienda Ospedaliera Universitaria Integrata VeronaUpdated: Dec 17, 2025Locations: 1
Eligibility criteria
Subjects of both sexes, affected by cystic fibrosis, attending the CF Center in... [+10]
Patients on any CFTR modulator therapy [+18]